{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:24:05Z","timestamp":1791239045753,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to investigate the correlation of minimum inhibiting concentrations (MICs), obtained by broth micro-dilution, and clinical response in patients with cryptococcal meningitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using retrospective analyses covering the period 2001\u20132010, factors affecting clinical therapeutic cure in patients with cryptococcal meningitis 10 weeks after the start of anti-fungal therapy were identified. Specific emphasis was placed on the role of anti-fungal susceptibility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 46 patients with cryptococcal meningitis identified, 21 were cured after 10 weeks of treatment. Overall, 12 strains (26.1%) were resistant to fluconazole (&gt;8 \u03bcg\/ml) and 8 (17.4%) had an MIC &gt;1 \u03bcg\/ml for amphotericin B. Twenty-three patients received combination amphotericin B and fluconazole as their initial antifungal therapy, 17 were given amphotericin B only, five received fluconazole only, and one received a combination of amphotericin B and flucytosine. After 2 weeks, all patients received fluconazole (400\u2013600 mg daily for 8 weeks at least, then 200 mg daily thereafter). The presence of isolates resistant to fluconazole (MIC &gt;8 \u03bcg\/ml; 4.8% vs. 44%,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) were statistically significant among patients who were cured. Anti-fungal susceptibility, reflected by fluconazole MIC &gt;8 \u03bcg\/ml, was an independent predictor of therapeutic cure at 10-week evaluation (OR\u2009=\u200915.7; 95% CI: 1.8-135.9;<jats:italic>p<\/jats:italic>\u2009=\u20090.01), but higher MIC of amphotericin B (&gt;1 \u03bcg\/ml) was not.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The MICs of fluconazole, determined by the CLSI method, may be a potential predictor of therapeutic cure in patients with cryptococcal meningitis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-12-361","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:53:24Z","timestamp":1356004404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis"],"prefix":"10.1186","volume":"12","author":[{"given":"Chen-Hsiang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jien-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chih","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"2166_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","volume":"8","author":"TG Mitchell","year":"1995","unstructured":"Mitchell TG, Perfect JR: Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev. 1995, 8: 515-548.","journal-title":"Clin Microbiol Rev"},{"key":"2166_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC: Practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010, 50: 291-322. 10.1086\/649858.","journal-title":"Clin Infect Dis"},{"key":"2166_CR3","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1128\/AAC.45.11.3065-3069.2001","volume":"45","author":"ME Brandt","year":"2001","unstructured":"Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW, Cryptococcal Disease Active Surveillance Group: Trends in anti-fungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother. 2001, 45: 3065-3069. 10.1128\/AAC.45.11.3065-3069.2001.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/clinids\/23.6.1337-a","volume":"23","author":"A Armengou","year":"1996","unstructured":"Armengou A, Porcar C, Mascar\u00f3 J, Garc\u00eda-Bragado F: Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1996, 23: 1337-1338.","journal-title":"Clin Infect Dis"},{"key":"2166_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/clinids\/19.5.975-a","volume":"19","author":"A Paugam","year":"1994","unstructured":"Paugam A, Camet-Dupouy J, Blanche P, Gangneux JP, Tourte-Schaefer C, Sicard D: Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis. 1994, 19: 975-976.","journal-title":"Clin Infect Dis"},{"key":"2166_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1086\/517056","volume":"26","author":"J Berg","year":"1998","unstructured":"Berg J, Clancy CJ, Nguyen MH: The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin Infect Dis. 1998, 26: 186-187.","journal-title":"Clin Infect Dis"},{"key":"2166_CR7","volume-title":"Reference method for broth dilution anti-fungal susceptibility testing of yeasts; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution anti-fungal susceptibility testing of yeasts; approved standard. 2008, CLSI document M27\u2013A3, CLSI, Wayne, PA, 3","edition":"3"},{"key":"2166_CR8","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1128\/AAC.01520-05","volume":"50","author":"E Dannaoui","year":"2006","unstructured":"Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F, French Cryptococcosis Study Group: Results obtained with various anti-fungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother. 2006, 50: 2464-2470. 10.1128\/AAC.01520-05.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/clinids\/22.2.322","volume":"22","author":"MD Witt","year":"1996","unstructured":"Witt MD, Lewis RJ, Larsen RA, Milefchik EN, Leal MA, Haubrich RH, Richie JA, Edwards JE, Ghannoum MA: Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of anti-fungal susceptibility testing. Clin Infect Dis. 1996, 22: 322-328. 10.1093\/clinids\/22.2.322.","journal-title":"Clin Infect Dis"},{"key":"2166_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","volume":"44","author":"AI Aller","year":"2000","unstructured":"Aller AI, Martin-Mazuelos E, Lozano F, Gomez-Mateos J, Steele-Moore L, Holloway WJ, Guti\u00e9rrez MJ, Recio FJ, Espinel-Ingroff A: Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother. 2000, 44: 1544-1548. 10.1128\/AAC.44.6.1544-1548.2000.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference","year":"1992","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874. 10.1097\/00003246-199206000-00025.","journal-title":"Crit Care Med"},{"key":"2166_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/377208","volume":"37","author":"PC Liliang","year":"2003","unstructured":"Liliang PC, Liang CL, Chang WN, Chen HJ, Su TM, Lu K, Lu CH: Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immuno-deficiency virus-negative patients. Clin Infect Dis. 2003, 37: 673-678. 10.1086\/377208.","journal-title":"Clin Infect Dis"},{"key":"2166_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/qjmed\/94.5.247","volume":"94","author":"SH Lan","year":"2001","unstructured":"Lan SH, Chang WN, Lu CH, Lui CC, Chang HW: Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. QJM. 2001, 94: 247-253. 10.1093\/qjmed\/94.5.247.","journal-title":"QJM"},{"key":"2166_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1439-0507.2007.01357.x","volume":"50","author":"S Ito-Kuwa","year":"2007","unstructured":"Ito-Kuwa S, Nakamura K, Aoki S, Vidotto V: Serotype identification of Cryptococcus neoformans by multiplex PCR. Mycoses. 2007, 50: 277-281. 10.1111\/j.1439-0507.2007.01357.x.","journal-title":"Mycoses"},{"key":"2166_CR15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.42.2.471","volume":"42","author":"MH Nguyen","year":"1998","unstructured":"Nguyen MH, Yu CY: In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob Agents Chemother. 1998, 42: 471-472.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR16","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JCM.36.10.2817-2822.1998","volume":"36","author":"M Lozano-Chiu","year":"1998","unstructured":"Lozano-Chiu M, Paetznick VL, Ghannoum MA, Rex JH: Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol. 1998, 36: 2817-2822.","journal-title":"J Clin Microbiol"},{"key":"2166_CR17","first-page":"87","volume":"66","author":"YL Yu","year":"1988","unstructured":"Yu YL, Lau YN, Woo E, Wong KL, Tse B: Cryptococcal infection of the nervous system. Q J Med. 1988, 66: 87-96.","journal-title":"Q J Med"},{"key":"2166_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1469-0691.2006.01367.x","volume":"12","author":"HY Sun","year":"2006","unstructured":"Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC: Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immuno-deficiency virus and treated with highly active anti-retroviral therapy. Clin Microbiol Infect. 2006, 12: 381-388. 10.1111\/j.1469-0691.2006.01367.x.","journal-title":"Clin Microbiol Infect"},{"key":"2166_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJM199201093260202","volume":"326","author":"MS Saag","year":"1992","unstructured":"Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Dismukes WE, The NIAID Mycoses Study Group and the AIDS Clinical Trials Group: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med. 1992, 326: 83-89. 10.1056\/NEJM199201093260202.","journal-title":"N Engl J Med"},{"key":"2166_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7326\/0003-4819-104-2-234","volume":"104","author":"A Zuger","year":"1986","unstructured":"Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ: Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986, 104: 234-240.","journal-title":"Ann Intern Med"},{"key":"2166_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/clinids\/12.5.768","volume":"12","author":"RA Clark","year":"1990","unstructured":"Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N: Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immuno-deficiency virus. Rev Infect Dis. 1990, 12: 768-777. 10.1093\/clinids\/12.5.768.","journal-title":"Rev Infect Dis"},{"key":"2166_CR22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/jcm.31.5.1370-1372.1993","volume":"31","author":"E Anaissie","year":"1993","unstructured":"Anaissie E, Shawar R, Paetznick V, Ensign LG, Witte Z, LaRocco M: Two-site comparison of broth micro-dilution and semi-solid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media. J Clin Microbiol. 1993, 31: 1370-1372.","journal-title":"J Clin Microbiol"},{"key":"2166_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.40.3.822","volume":"40","author":"SP Franzot","year":"1996","unstructured":"Franzot SP, Hamdan JS: In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five anti-fungal drugs. Antimicrob Agents Chemother. 1996, 40: 822-824.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR24","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.00295-09","volume":"53","author":"E Sionov","year":"2009","unstructured":"Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ: Hetero-resistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother. 2009, 53: 2804-2815. 10.1128\/AAC.00295-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/AAC.00742-06","volume":"51","author":"RA Larsen","year":"2007","unstructured":"Larsen RA, Bauer M, Brouwer AE, Sanchez A, Thomas AM, Rajanuwong A, Chierakul W, Peacock SJ, Day N, White NJ, Rinaldi MG, Harrison TS: In vitro clinical correlation for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis. Antimicrob Agents Chemother. 2007, 51: 343-345. 10.1128\/AAC.00742-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR26","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1128\/AAC.00034-11","volume":"55","author":"RA Larsen","year":"2011","unstructured":"Larsen RA, Bauer M, Pitisuttithum P, Sanchez A, Tansuphaswadikul S, Wuthiekanun V, Peacock SJ, Simpson AJ, Fothergill AW, Rinaldi MG, Bustamante B, Thomas AM, Altomstone R, Day NP, White NJ: Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome. Antimicrob Agents Chemother. 2011, 55: 5624-5630. 10.1128\/AAC.00034-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"2166_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7883\/yoken.JJID.2004.113","volume":"57","author":"WN Chang","year":"2004","unstructured":"Chang WN, Huang CR, Lei CB, Lee PY, Chien CC, Chang HW, Chang CS, Lu CH: Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole. Jpn J Infect Dis. 2004, 57: 113-115.","journal-title":"Jpn J Infect Dis"},{"key":"2166_CR28","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS: Combination anti-fungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004, 363: 1764-1767. 10.1016\/S0140-6736(04)16301-0.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-361\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:06:54Z","timestamp":1745464014000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-361","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"17 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"361"}}